about
Shear stress modulation of IL-1β-induced E-selectin expression in human endothelial cellsDynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.Effect of PEGylation on ligand-based targeting of drug carriers to the vascular wall in blood flow.Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters.Kinetics of LFA-1 mediated adhesion of human neutrophils to ICAM-1--role of E-selectin signaling post-activation.Fabrication of biodegradable spheroidal microparticles for drug delivery applications.Margination propensity of vascular-targeted spheres from blood flow in a microfluidic model of human microvessels.Laminar shear stress elicit distinct endothelial cell E-selectin expression pattern via TNFα and IL-1β activation.The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow.Neutrophil-Particle Interactions in Blood Circulation Drive Particle Clearance and Alter Neutrophil Responses in Acute Inflammation.Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers.Presence of Rigid Red Blood Cells in Blood Flow Interferes with the Vascular Wall Adhesion of Leukocytes.Modified two-step emulsion solvent evaporation technique for fabricating biodegradable rod-shaped particles in the submicron size range.Particle-cell dynamics in human blood flow: implications for vascular-targeted drug delivery.The influence of red blood cell deformability on hematocrit profiles and platelet marginationVascular-targeted particle binding efficacy in the presence of rigid red blood cells: Implications for performance in diseased blood
P50
Q21134771-8101007C-93D1-45BF-9333-EBC9639D8CA8Q37771030-22CC1C9A-04B5-4663-B0BE-7BF63A8528A8Q37804385-19C2B45B-F182-409A-A9CE-3CE164095081Q38313607-692CE4C5-054D-4756-96C0-2369ECB3063FQ38334991-E5C2ECE5-6FB5-479F-BD48-1B4B916CEA79Q39888793-A57EFC04-0F0F-4FB1-B63C-4F4037645B47Q43447580-9F390C68-5E4D-49E6-9CAE-E8474B69E1E6Q43865918-B24452C8-8840-43DB-BFD0-53434927155CQ44230633-D598149B-594B-4D88-85CF-294157306D1EQ45942845-4FE98BA0-C6DD-4C5B-873D-A281410249CDQ47447868-5541B5B5-8978-470D-B4DC-47A1DCD14ACDQ47582525-F5744BC1-B751-4D42-927A-E5F9346B8152Q48022456-0B6FE442-BACC-49BF-B0D1-553B2D755CD3Q49902777-81DD2894-939F-4B70-8AB0-FEC89A482799Q50502950-8A3007A6-8B7D-4F73-AE16-B8E039078B73Q90262474-59E78AD2-9265-4BC5-8D23-3DBB2361D376Q90298628-E46CB1ED-4263-4EC8-BA62-C308A78D0F78
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Omolola Eniola-Adefeso
@ast
Omolola Eniola-Adefeso
@en
Omolola Eniola-Adefeso
@es
Omolola Eniola-Adefeso
@nl
Omolola Eniola-Adefeso
@sl
type
label
Omolola Eniola-Adefeso
@ast
Omolola Eniola-Adefeso
@en
Omolola Eniola-Adefeso
@es
Omolola Eniola-Adefeso
@nl
Omolola Eniola-Adefeso
@sl
prefLabel
Omolola Eniola-Adefeso
@ast
Omolola Eniola-Adefeso
@en
Omolola Eniola-Adefeso
@es
Omolola Eniola-Adefeso
@nl
Omolola Eniola-Adefeso
@sl
P106
P1153
26021803700
P21
P31
P496
0000-0002-8728-6608
P569
2000-01-01T00:00:00Z